沃森生物(300142.SZ)擬斥5億元參設健康產業投資基金
格隆匯12月31日丨沃森生物(300142.SZ)公佈,2019年12月30日,公司第四屆董事會第五次會議審議通過了《關於公司參與投資設立健康產業投資基金的議案》。為促進公司產業鏈進一步拓展,公司將以自有資金出資5億元與合作方共同投資設立沃康生物醫藥健康產業投資基金(有限合夥)(基金名稱以最終工商登記註冊為準,“基金”),並授權公司董事長簽署相關協議,辦理基金設立、出資、退出等相關事宜。公司參與投資設立該基金旨在推進實施公司的投資戰略,充分利用國家相關優惠政策及便利,通過與外部機構合作,利用專業的投資平台幫助公司更加有效地篩選和孵化投資項目,經過前期對被投資項目進行有效整合,可減少後期併購風險,提高公司盈利能力。
沃康生物醫藥健康產業投資基金(有限合夥)(名稱以最終工商登記註冊為準)投資方向:聚焦與公司主營業務相關的生物醫藥及生物技術領域進行投資。
公司參與投資設立該基金旨在推進實施公司的投資戰略,充分利用國家相關優惠政策及便利,通過與外部機構合作,利用專業的投資平台幫助公司更加有效地篩選和孵化投資項目,經過前期對被投資項目進行有效整合,可減少後期併購風險,提高公司盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.